Sugar-lowering effects of bitter leaf (Vernonia amygdalina) in experimental broiler finisher chickens

Asian Journal of Pharmaceutical and Clinical Research

Volumn 4, Issue SUPPL. 1, 2011, Pages 19-21

  Owen, O J ^a   Amakiri, A O ^a   Karibi Botoye, T A ^b  

^a RIVERS STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Nigeria)

^b UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

Anti diabetic; Biomolecules; Broilers; Hypoglycaemic; Toxicity; V. amygdalina

Indexed keywords

CREATININE; GLOBULIN; GLUCOSE; HERBACEOUS AGENT; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BROILER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; NONHUMAN; PLANT LEAF; PROTEIN BLOOD LEVEL; UREA BLOOD LEVEL; VERNONIA; VERNONIA AMYGDALINA;

EID: 80052904775     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Adewole, S.O. and Caxton-Martins, E.A. (2006). Morphological and hypoglycaemic effects of Annona muricata Linn (Annonaceae) leaf aqueous extract on pancreatic B cells of streptozotocin-treated diabetic rats. Afr. J. Biomed. Res. 9: 173-187.
2. Adewole, S.O.; Ojewole, J.A. and Caxton-Martins, E.A. (2007). Protective effects of quercetin on the morphology of pancreatic B cells of stretozotocine treated diabetic rats. Afri. J. Traditional Compl. Alternative Med. 4:64-74.
3. Aguwa, C.N. (1996). Diabetes mellitus. In: Therapeutic basis of climate pharmacy in the tropics. Optimal publishers, Enugu, Nigeria. pp. 1-453.
4. Ahmad, L.; F. Agil and M. Owais (2006). Modern phytomedicine. Turning Medicine Plants into Drugs. West-Susex England: John Wiley and Sons, pp: 2-24
5. Akah, P.A. and Okafor, C.I. (1992). Blood sugar lowering effect of V. amaygdalina Del. In Experimental rabbit model Phytother. Res., 6: 171-173.
6. Akimola, O.S.; Akimola, O.B., and Caxton-Martins, E.A. (2009). Vernonia amygdalina regulates hepatic enzymes and improves liver micromatomy in experimental diabetes mellitus. Pharmacologyonline, 2: 1231-1242.
7. Akinpelu, D.A. (1999). Antimicrobial activity of Vernonia amygdalina leaves. Fitoterapia J. Study Med. Plants. 70: 432-435.
8. Areghore, E.M., Makkar, H.P.S and Becker, K (1997).Chemical composition and tannins in leaves of some browse plants from Delta (Central Nigeria) eaten by ruminants. Proc. Soc. Nutr. Physiol., 5:11-15
9. Atangwho, I.J.; Egbon, P.E.; Eteng, M.U., Eyong, E.U. and Obi, A.U. (2007). Effect of V. amaygdalina Del. Leaf on kidney function of diabetic rats. Int. J. Pharm., 3 (2): 142-148.
10. Chattopadhyay, R.R. (1993). Effect of A. indica on leaf extract on hepatic glycogen in rats. Ind. J. Pharm, 25: 174-175.
11. Ebong, P.E; I.J. Atangwho; E.U. Eyong and G.E. Egbung (2008). The anti-diabetic efficacy of combined extracts from two continental plants: Azadirachta indica (Neem) and Vernonia amygdalina (bitter leaf). American Journal of Biochemical and Biotechnology, 4(3): 239-244.
12. Ekpo, A.; Eseyin, O.A.; Ikpeme, A.O. and Eddio, E.J. (2007). Studies on some biochemical effects of V. amaygdalina in rats. Asian Journal of Biochemistry 2 (3): 193-197.
13. Erasto, P.; Grierson, D.S. and Afolanyan, A.J. (2006). Bioactive sequiterpene lactones from the leaves of Vernonia amaygdalina. J. Ethnophermacol. 106: 117-120.
14. Ezekwe, C.I. and O. Obidoa (2001). Biochemical effect of V. amaygdalina on rat liver microsomes. Nig. J. Biochem. Mol. Biol, 16. 1745-1788.
15. Hottettmann, K., A. Marston, K. Ndjoko and J. Wolfender (2000). The potential of African plants as a source of Drug. Curr. Org. Chem., 4: 973-1010.
16. Igile, G.O.; Oleszek, S.B.; Burda S.; Jurzysta, M.(1995b). Nutritional assessment of Vernonia amygdalina leaves in growing mice Journal of Agric. Food Chem., 43:2162-2166
17. Igile, G.O.; Oleszek, S.B.; Jurzysta, M.; Aquino, R.; Tommas, N. and Pizza, C. (1995a). Vernoniosides D and E. Two novel saponins from Vernonia amygdalina. Del. J. Nat. Prod. 58: 1438-1443.
18. Igile, G.O.; Olezek, W.; Juryzysta, M. (1994). Flavonoids from V. amaygdalina and their antioxidant activities. J. Agric. Food Chem 42: 2445-2448.
19. Jisaka, M.; Ohigashi, H., Takagaki, T. (1992). Bitter steroid glucosides, vernonisides A1, A2, A3and related B1, from a possible medicinal plant V. amaygdalina used by wild Chimpanzees. Tetrahedron. 48: 625-632.
20. Kim, J.S.; Ju, J.B.; Choi, C.W. and Kin, S.C. (2006). Hypoglycaemic and antihyperglycaemic effect of four Korean medicinal plants in alloxan induced diabetic rats. Am. J. Biochem. Biotech., 2 (4): 154-160.
21. Mann, J.I. (1980). Diet and diabetes. Diabetologia, 18: 89-95.
22. Masaba, S.C. (2000). The antimalarial activity of some traditional medicinal plants. Ethiopian J. Health Develop., 13: 211-216.
23. Naidu, R. (1992). Dietary advice for diabetics in Africa. International Diabeics Digest, 3 (4): 114-118
24. Nwajo, H.U. (2005). Efficacy of aqueous leaf extract of Vernonia amygdalina on plasma lipoproteins and oxidative status in diabetic rat model. Nig. J. Physiol. Sci. 20: 39-42.
25. Nwanjo, H.U and Nwokoro, E.A. (2004). Anti-diabetic and biochemical effects of aqueous extract of V. amygdalina leaf in normoglycaemic and diabetic rats. J. Innov. Life Sci. 7:6-10.
26. nded. Snap Press, Enugu-Nigeria.
27. Ohiagashi, M.(1994). Assessment of antibacterial activity of some traditional medicine plants. Ethiopian J. Health Develop.,13:211-216
28. Ojewole, J.A.O. (2006). Antinociceptive, anti-inflammatory and antidiabetic effects of Bryophyllum pinnatum (crassulaceae) leaf aqueous extract. J. Ethnopharmacol. 99: 13-19.
29. Ojiako, O.A. and Nwanjo, H.U. (2006). Is Vernonia amygdalina hepatotoxic or hepatoprotective. Response from biochemical and toxicity studies in rats. Afric. J. Biotech. 5 (18): 1648-1651.
30. thSeptember, Ogbomoso, Oyo State. Pp 173-176.
31. Rates, S.M. (2001). Plants as sources of Drugs. Toxican, 39 (5). 603-613.
32. Sonia, B. and Srinirasan, B.P. (1999). Investigation into the anti-diabetic activity of A. indica. Ind. J. Pharm. 31:138-141.
33. nded. MacGraw-Hill. Singapore.
34. Taiwo, I.A.; Odeigah, P.G.C and Ogunknmi, L.A. (2009). The glycaemic effects of V. amaygdalina and V. tenoreana with tolbutamide in rats and implications for the treatment of diabetes mellitus. Journal Science Research Development, 11: 122-130.
35. Tiwari, A.K. and J.M. Rao (2002). Diabetes mellitus and multiple therapeutic approaches of phytochemical: Present status and future prospects. Curr. Sci., 83 (1): 30-37.
36. Uhegbu, F.O. and Ogbuehi, K.J. (2004). Effect of the aqueous extract (crude) of leaves of Vernonia amygdalina on blood glucose, serum cholesterol and serum albumin levels in alloxan induced diabetic albino rats. Global J. Pure Appl. Sci. 10: 189-194.
37. WHO (World Health Organization) (1980). Second report of the WHO Expert Committee on Diabetes Mellitus. Technical Report Series 646, Genera, pp: 66.